Cargando…

Systematic Pan-Cancer Population-Based Analysis Reveals the Incidence and Prognosis of Lung Metastases at Diagnosis

BACKGROUND: Metastasis is one of the most prevalent causes of death in cancer patients and the lungs are among the organs most commonly affected by metastasis. However, analysis of the incidence and prognosis of lung metastasis (LM) based on primary cancer sites is lacking. METHODS: We enrolled canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Xiaohong, Cheng, Yinan, Zhou, Weijun, Ni, Jun, Li, Yuqing, Feng, Gaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221885/ https://www.ncbi.nlm.nih.gov/pubmed/34221015 http://dx.doi.org/10.1155/2021/9999968

Ejemplares similares

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
por: Gong, Yue, et al.
Publicado: (2018)

Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma
por: Liang, Xiaohong, et al.
Publicado: (2020)

Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma
por: Mi, Jinglin, et al.
Publicado: (2022)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Identification of Potential Biomarkers for Pan-Cancer Diagnosis and Prognosis Through the Integration of Large-Scale Transcriptomic Data
por: Zhu, Lin, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis
por: Ching, Travers, et al.
Publicado: (2016)

Value of ablation therapy in the treatment of lung metastases
por: Qi, Han, et al.
Publicado: (2017)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

Estimate of the incidence of PANDAS and PANS in 3 primary care populations
por: Wald, Ellen R., et al.
Publicado: (2023)

Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study
por: Huang, Jin-Feng, et al.
Publicado: (2020)

Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients
por: Zhao, Feng, et al.
Publicado: (2019)

A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis
por: Zhang, Leiming, et al.
Publicado: (2023)

Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis
por: Lee, Min-Ho, et al.
Publicado: (2013)

Incidence and consequences of bone metastases in lung cancer patients
por: Kuchuk, Michael, et al.
Publicado: (2013)

Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study
por: Zhang, Jing, et al.
Publicado: (2023)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
por: Cui, Zhiwei, et al.
Publicado: (2023)

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
por: Jiao, Zonglin, et al.
Publicado: (2022)

Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma
por: Liu, Shuwen, et al.
Publicado: (2021)

Genetic and Molecular Characterization Revealed the Prognosis Efficiency of Histone Acetylation in Pan-Digestive Cancers
por: Zhang, Tao, et al.
Publicado: (2022)

Pan-Cancer Analysis of TLE3 Revealed Its Value in Tumor Microenvironment and Prognosis
por: Li, Tianyu, et al.
Publicado: (2022)

Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
por: Qiao, Han, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Lung cancer revealed by multiple metastases of the scalp
por: Fetohi, Mohamed, et al.
Publicado: (2016)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
por: Krawczyk, Paweł, et al.
Publicado: (2013)

The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis
por: Zakaria, Rasheed, et al.
Publicado: (2014)

Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study
por: Zheng, Xuan, et al.
Publicado: (2023)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
por: Jin, Jia, et al.
Publicado: (2018)

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

Delayed postoperative radiotherapy increases the incidence of radiographic local tumor progression before radiotherapy and leads to poor prognosis in spinal metastases
por: Gong, Yining, et al.
Publicado: (2021)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers
por: Jiangzhou, Huiting, et al.
Publicado: (2021)

Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
por: Wang, Yuqi, et al.
Publicado: (2023)

A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment
por: Gong, Xun, et al.
Publicado: (2023)

A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors
por: Fu, Yizhe, et al.
Publicado: (2023)

Development and validation of prediction models for the prognosis of colon cancer with lung metastases: a population-based cohort study
por: Ma, Zhenyu, et al.
Publicado: (2023)

Potential applications of MEG3 in cancer diagnosis and prognosis
por: He, Yuqing, et al.
Publicado: (2017)

Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics
por: Chen, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rts97680u4slid6ufm7r1k36h1